Titre :
  • Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Auteur : Chia, Stephen ; Gradishar, William J. ; Mauriac, L ; Bines, Jose ; Amant, F. ; Federico, Miriam ; Fein, Luis ; Romieu, Gilles ; Buzdar, Aman ; Robertson, John F R ; Brufsky, Adam ; Possinger, Kurt ; Rennie, Pamela ; Sapunar, Francisco ; Lowe, Elizabeth ; Piccart-Gebhart, Martine
Informations sur la publication : Journal of clinical oncology, 26, 10, (page 1664-1670)
Statut de publication : Publié, 2008-04
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Androstadienes -- therapeutic use
Antineoplastic Agents -- therapeutic use
Aromatase Inhibitors -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- metabolism
Breast Neoplasms -- mortality
Double-Blind Method
Estradiol -- analogs & derivatives
Estradiol -- therapeutic use
Female
Humans
Kaplan-Meiers Estimate
Neoplasm Recurrence, Local -- drug therapy
Placebos
Postmenopause
Quality of Life
Receptors, Estrogen -- metabolism
Note : Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2007.13.5822
info:pii/JCO.2007.13.5822
info:pmid/18316794